Novartis has marked its 25 years of development with a certificate of merit from Vietnam’s Ministry of Health for its social commitment during the Covid-19 pandemic.
“This achievement affirms Novartis’s leading position in the global pharmaceutical market and its long-term commitment to community health support,” a Novartis representative stated.
Over the past 25 years, Novartis has achieved medical breakthroughs in cancer care, heart disease and the fight against inflammatory conditions. The company uses innovative science and technology to address some of society’s most challenging healthcare issues. It discovers and develops breakthrough treatments and finds new ways to deliver them to as many people as possible.
Partner of Vietnam’s healthcare
Novartis began its journey in Vietnam in the 1950s through the presence of Sandoz, Ciba-Geigy, and other partners. Over the past two decades in the country, Novartis Vietnam has cooperated with the Ministry of Health (MoH) and domestic and international organizations to launch several programs to enhance public health awareness, promote training, and strengthen primary healthcare in many cities and provinces.
In 2008, the representative office of Novartis Pharma Services AG was established in Vietnam to promote and support the supply of medicines, and delivery of drugs to patients, as well as clinical trials of Novartis Group.
Over the past 13 years, Novartis Vietnam has been focusing on four areas including science-based innovation and clinical trials; scientific and academic cooperation; quality and local manufacturing, along patient access to high-quality, innovative healthcare.
The company has collaborated with the MoH to develop a strong healthcare system that covers the lowest income segments of the population and to provide the Vietnamese people with high-quality medicines, thus contributing to the MoH’s objective to shape a strong and sustainable healthcare system and achieve universal healthcare coverage.
A lot of significant programs have been carried out over the past years. In 2014, Novartis and the MoH signed a Memorandum of Understanding (MoU) to enhance the Vietnamese people’s access to essential, affordable generic and innovative medicines, and strengthen the country’s science, medical, and technology capabilities
It is followed by another MoU inked in December 2019 on raising primary healthcare in Vietnam through activities at commune and district levels from 2019 to 2021, making it a testament to public-private collaboration in this area, aiming to achieve the Universal Healthcare Coverage and United Nations Sustainable Development Goals by 2030.
2020 marked a special milestone in Novartis Vietnam’s development journey when it inaugurated its new legal entity in the country and became one of the first multinational companies to successfully transform from a representative office to a foreign-invested enterprise importer. Also that year, the company was honored as a pioneer in digital transformation for its efforts and outstanding contributions to the Digital Transformation of the Healthcare Sector at National Digital Transformation Congress.
Moreover, Novartis Vietnam teamed up with Docquity to offer an exclusive digital network for medical staff. The company has also been named among the top 100 Vietnam Best Places to Work in the country thanks to its appropriate human resource policies and quick response to the Covid-19 pandemic.
In 2021, the company keeps the momentum of good performance with its recognition as a Global Top Employer for 2021, thus contributing to encouraging Novartis to continue attracting talents and strengthening its offering as a destination for employers in the future.
Contributions to the Covid-19 fight
Novartis received the certificate of merit from the MoH for its social commitment during the Covid-19 pandemic and its contributions to the country’s Covid fight, and training of HCPs, among others.
Novartis supports the initiative of six medical universities in Vietnam to train HCPs to serve Covid-19 prevention and control. At least 1,800 final-year medical students got training from April to July 2020. This effort was in response to the call of the government and the MoH, mobilizing more than 90,000 HCPs for the pandemic fight.
Moreover, the company has so far donated over $400,000 to the pandemic battle in Vietnam. The company also joined hands with other members of EuroCham Pharma Group to donate an equivalent total of $100,000 to the Vietnam Fatherland Front national campaign on the prevention and treatment of Covid-19, and donate via the HCMC Red Cross Society medical supplies to frontline hospitals, and Covid-19 treatment centers.
During the pandemic, Novartis has taken effective measures to ensure the continuation of the supply of medicines, as well as promote technology application to maintain regular medical training for HCPs, thus ensuring healthcare access.
Amitabh Dube, country president, Novartis Vietnam, said: “Vietnam and countries worldwide are still facing pressing health issues that need more innovations to address them. Novartis commits to be a reliable partner in this effort, and will continue the discovery and development of new treatments to help more people.”
Long-term investment commitments
Novartis’s strategy is to build a leading, focused pharmaceutical company powered by advanced therapy platforms and data science. Looking at the next 25 years and beyond, the company will continue reimagining medicine to improve and extend people’s lives.
To implement the strategy, Novartis has five priorities to shape its future and help it continue to create value for the company, its shareholders and society: unleash the power of its people; deliver transformative innovation; embrace operational excellence; go big on data and digital; and build trust with society.
In Vietnam, the company will continue to collaborate with Vietnamese societies, associations, and health facilities in programs to improve healthcare services for Vietnamese, showing its strong commitment to accompanying the local health sector in future sustainable development.
